NBDC Research ID: hum0479.v1

 

SUMMARY

Aims: To explore new biomarkers for predicting the effectiveness of an anti-epidermal growth factor receptor (anti-EGFR) antibody in patients with advanced colorectal cancer. The investigation involves analyzing the entire exome, conducting a genome-wide association study (GWAS), and analyzing copy number variations (CNVs) using single nucleotide polymorphism (SNP) arrays. Genetic material from both tumor and non-tumor tissues, as well as blood samples from patients who received the anti-EGFR antibody treatment, were used. The goal is to identify genetic mutations and SNPs associated with treatment efficacy and adverse events, and to assess the correlation between their presence and treatment effectiveness using statistical methods.

Methods: Whole exome sequencing for exploratory cohort, Target capture sequencing for inference cohort

Participants/Materials: Unresectable and advanced recurrent colorectal cancer

- exploratory cohort: 92 patients treated with cetuximab

- inference cohort: 150 patients treated with cetuximab or panitumumab

 

Dataset IDType of DataCriteriaRelease Date
JGAS000779

NGS (Exome)

NGS (Target Capture)

Controlled-access (Type I) 2025/04/14

*Release Note

* Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

 

MOLECULAR DATA

Exome

Participants/Materials

Unresectable and advanced recurrent colorectal cancer (ICD10: C18.9): 92 cases

     tumor and non-tumor tissue pairs: 92 cases (184 samples)

Targets Exome
Target Loci for Capture Methods -
Platform Illumina [Hiseq 2000/1500]
Library Source DNAs extracted from tumor and non-tumor tissues
Cell Lines -
Library Construction (kit name) SureSelect Human All Exon V4+UTRs Kit
Fragmentation Methods Ultrasonic fragmentation (Covaris)
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 100 bp
Mapping Methods BWA
Mapping Quality -
Reference Genome Sequence hg19
Coverage (Depth) x161
Japanese Genotype-phenotype Archive Dataset ID JGAD000921
Total Data Volume 8.4 TB (bam)
Comments (Policies) NBDC policy

 

Target Capture

Participants/Materials

Unresectable and advanced recurrent colorectal cancer (ICD10: C18.9): 150 cases

     tumor tissues : 63 cases (63 samples)

     tumor and non-tumor tissue pairs : 87 cases (174 samples)

Targets Target Capture
Target Loci for Capture Methods 31 genomic loci found in the first cohort. (Gene list)
Platform Illumina [Hiseq 2000/1500]
Library Source DNAs extracted from tumor and non-tumor tissues
Cell Lines -
Library Construction (kit name) SureSelect Human All Exon V4+UTRs Kit
Fragmentation Methods Ultrasonic fragmentation (Covaris)
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 100 bp
Mapping Methods BWA
Mapping Quality -
Reference Genome Sequence hg19
Coverage (Depth) x694
Japanese Genotype-phenotype Archive Dataset ID JGAD000921
Total Data Volume 8.4 TB (bam)
Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Katsuya Tsuchihara

Affiliation: Exploratory Oncology Research and Clinical Trial Center, National Cancer Center

Project / Group Name: BREAC Study

URL: -

Funds / Grants (Research Project Number):

NameTitleProject Number
Adaptable and Seamless Technology transfer Program through targetdriven R&D, Japan Science and Technology Agency (JST) Development of a Predictive Diagnostic Kit for Evaluating the Efficacy of Anti-EGFR Antibody Therapy Based on Comprehensive Genomic Analysis JPMJTT11S8

 

PUBLICATIONS

TitleDOIDataset ID
1 Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study doi:10.1038/bjc.2017.308 JGAD000921
2

 

USRES (Controlled-access Data)

Principal InvestigatorAffiliationCountry/RegionResearch TitleData in Use (Dataset ID)Period of Data Use